Pérez, Angela V <br/><br/>
Evaluating the centralized purchasing policy for the treatment of hepatitis C: The Colombian CASE.  [electronic resource] 

 -  Pharmacology research & perspectives  12 2019 
 - e00552 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2052-1707 
<br/><br/><label>Standard No.: </label>10.1002/prp2.552  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--economics<br/>Colombia--epidemiology<br/>Cost Savings--economics<br/>Cost-Benefit Analysis<br/>Delivery of Health Care--economics<br/>Drug Costs--legislation & jurisprudence<br/>Drug Industry--economics<br/>Female<br/>Group Purchasing--economics<br/>Health Plan Implementation<br/>Hepacivirus--isolation & purification<br/>Hepatitis C--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Negotiating<br/>Policy<br/>Practice Guidelines as Topic<br/>Program Evaluation<br/>Stakeholder Participation<br/>Treatment Outcome